1302 — LifeTech Scientific Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual cashflow statement for LifeTech Scientific, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	C2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	333	378	176	199	191
Depreciation
Amortisation
Non-Cash Items	-3.9	86.1	272	146	234
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	55.7	-136	-98.3	-103	29.9
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	441	388	418	321	549
Capital Expenditures	-276	-226	-206	-205	-69.7
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	237	-232	-248	-312	-57.6
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities	-39	-458	-454	-518	-127
Financing Cash Flow Items	14.7	0.158	10.8	36.2	23.8
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-256	-215	183	-117	-370
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	148	-285	146	-314	53.6